chr4-87046696-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_001166693.3(AFF1):c.161C>T(p.Thr54Ile) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,586,632 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001166693.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AFF1 | NM_001166693.3 | c.161C>T | p.Thr54Ile | missense_variant, splice_region_variant | 4/21 | ENST00000395146.9 | NP_001160165.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AFF1 | ENST00000395146.9 | c.161C>T | p.Thr54Ile | missense_variant, splice_region_variant | 4/21 | 2 | NM_001166693.3 | ENSP00000378578 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151838Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000128 AC: 3AN: 234156Hom.: 0 AF XY: 0.00000790 AC XY: 1AN XY: 126652
GnomAD4 exome AF: 0.0000418 AC: 60AN: 1434794Hom.: 0 Cov.: 31 AF XY: 0.0000436 AC XY: 31AN XY: 711322
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151838Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74134
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2022 | The c.161C>T (p.T54I) alteration is located in exon 4 (coding exon 3) of the AFF1 gene. This alteration results from a C to T substitution at nucleotide position 161, causing the threonine (T) at amino acid position 54 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at